Form 8-K - Current report:
SEC Accession No. 0001193125-24-278985
Filing Date
2024-12-16
Accepted
2024-12-16 06:06:59
Documents
14
Period of Report
2024-12-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d896239d8k.htm   iXBRL 8-K 25997
2 EX-3.1 d896239dex31.htm EX-3.1 111722
  Complete submission text file 0001193125-24-278985.txt   294815

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20241213.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20241213_lab.xml EX-101.LAB 18656
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20241213_pre.xml EX-101.PRE 11685
16 EXTRACTED XBRL INSTANCE DOCUMENT d896239d8k_htm.xml XML 3823
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 241550037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)